Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Mitchell S. Kapoor initiated coverage on Ascendis Pharma A/S (NASDAQ:ASND) with a Buy rating and announced a price target of $345. Ascendis Pharma closed at $250.25 on Wednesday. See how other analysts view this stock.
• Truist Securities analyst Miller Jump initiated coverage on DigitalOcean Holdings Inc (NYSE:DOCN) with a Buy rating and announced a price target of $175. DigitalOcean shares closed at $114.99 on Wednesday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Emily Bodnar initiated coverage on Odyssey Therapeutics, Inc. (NASDAQ:ODTX) with a Buy rating and announced a price target of $44. Odyssey Therapeutics closed at $25.62 on Wednesday. See how other analysts view this stock.

Considering buying ASND stock? Here’s what analysts think:

Photo via Shutterstock